The agencies, in a statement, stated that the countries
would receive 18 million doses of the first-ever vaccine against malaria over
the next two years.
The RTS,S vaccine had been administered to more than 1.6
million children in Ghana, Kenya and Malawi since 2019 and shown to be safe and
effective.
It resulted in a substantial reduction in severe malaria and
a fall in child deaths.
The WHO Director-General Tedros Ghebreyesus said malaria
remained one of Africa’s deadliest diseases, killing nearly half a million
children under the age of five every year, and accounting for approximately 96
per cent of global malaria deaths in 2021.
“With the climate crisis changing weather patterns,
mosquitoes that carry these diseases are increasing in density and spreading
further afield,” Ghebreyesus said,
speaking during his regular media briefing from Geneva.
The initial 18 million dose allocation will enable nine more
African countries to introduce the vaccine into their routine immunisation
programmes for the first time.
Those nations include Benin, Burkina Faso, Burundi,
Cameroon, the Democratic Republic of the Congo, Liberia, Niger, Sierra Leone
and Uganda.
The first doses are expected to arrive during the last
quarter of 2023, with rollout set to
start by early 2024.
“This vaccine has the potential to be very impactful in the
fight against malaria, and when broadly deployed alongside other interventions,
it can prevent tens of thousands of future deaths every year,” Thabani Maphosa,
Managing Director of Country Programmes Delivery at Gavi, said.
The partners said at least 28 African countries have
expressed interest in receiving the RTS,S vaccine, while a second malaria
vaccine is currently under review for pre-qualification, and if successful
provides additional supply in the short term.
0 comments:
Post a Comment